|
Brenipatide Clinical Trials
4 actively recruiting trials across 3 locations
▲ +2 trials since September 2026
Also known as: LY3537031
Pipeline
Phase 2: 2Phase 3: 2
Top Sponsors
- Eli Lilly and Company4
Indications
- Depression2
- Depressive Disorder, Major2
- Pulmonary Disease, Chronic Obstructive1
- Asthma1
- COPD1
Birmingham, Alabama2 trials
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
University of Alabama at Birmingham - School of Medicine
Phase 3
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
University of Alabama at Birmingham
Phase 2
Tempe, Arizona1 trial
Moorpark, California1 trial
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Accellacare - Moorpark
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.